Project SENS-IT-IV
Contact: Erwin L Roggen, www.sens-it-iv.eu
Test models included |
Genomic |
Cell differentiation |
Proteomic |
Ex vivo tissues/lung |
Enzyme-receptors |
Artificial skin |
Methods with commercial potential |
Properly evaluated testsystems |
|
|
|||
Endpoints |
Lung sensitisation |
|
|
|||
Expected field of application |
Chemicals |
Cosmetics and hygieneproducts |
Pharmaceuticals |
|||
Stage of development |
Basic research on mechanisticend point |
Optimization method |
In-house optimized |
|||
Expected regulatory acceptance |
EC-ECVAM |
|
|
|||
Expected interest from the market |
Specific end users arealready applying fortesting |
End users are interestedand supporting |
We know users whichare interested |
|||
Test models included |
Cell functions |
Cell proliferation |
|
|||
Methods with commercial potential |
|
|
|
|||
Endpoints |
|
|
|
|||
Expected field of application |
|
|
|
|||
Stage of development |
|
|
|
|||
Expected regulatory acceptance |
|
|
|
|||
Expected interest from the market |
A producer technology company is alreadycommercialising |
A producer technology company is interested in commercialising |
|
|||

